eSight earns Honorable Mention for Fast Company's 2021 World Changing Ideas! Read More>>

Empowering people with low vision

Breakthrough all-in-one enhanced vision wearable device.

See what’s possible with eSight

eSight moves seamlessly with wearers through daily life offering the best visual acuity whether sitting reading, commuting to work, or exploring a new place.

Suitcase icon

Excel in the careers of your choice

Gradate hat icon

Advance in school and academics

Shopping cart icon

Enjoy hobbies like golfing and baking

Video game controller icon

Read books, watch TV and more

Face icon

See faces in clearly, in detail

Airplane icon

Safely explore new places

Meet three eSight wearers

Hear how they felt when they learned about eSight, their first impressions using the device, and how eSight has changed their lives ever since.

Who can benefit from eSight?

eSight is used daily by people with over 20 different eye conditions, eSight enhances vision for people living with central vision loss, blurry vision, blind spots, and more. A typical eSight user has natural visual acuity of 20/60 to 20/800 but some have up to 20/1400. Many achieve 20/20 acuity with eSight.

  • Cataracts
  • Diabetic Retinopathy
  • Macular Degeneration
  • Ocular Albinism
  • Optic Atrophy
  • Retinopathy of Prematurity
  • Retinitis Pigmentosa
  • Retinal Detachment
  • Stargardt’s Disease
Before eSite 4 After eSite 4

Vision: With and Without Macular Degeneration

The Science behind eSight 

eSight captures high-quality video, and displays it on two high-resolution OLED screens, directly in front of each eye. Footage is enhanced by custom optics and proprietary algorithms to maximize functional sight. The result?  Synaptic activity from the remaining photoreceptor function in the user’s eyes is stimulated to provide the brain with increased visual information to naturally compensate for gaps in the users’ field of view.

Watch the how eSight works video

Trusted by low vision experts

eSight’s technological approach has been clinically-validated by six leading low vision institutions. The study is published in the Journal of Optometry and Vision Science (eQUEST, ClinicaTrials.gov Identifier NCT02616900), the eSight approach demonstrated:

line gain in distance acuity
percent mobility retention
letter contrast improvement

Skip to content